Mitochondrial disease manifestations in relation to transcriptome location and function.

Area of Science:

• Neuroscience
• Genetics
• Systems Biology

Background:

• Neurological disease manifestations are often linked to specific brain regions.
• Traditionally, gene function is considered broadly expressed, dissociating molecular mechanisms from regional correlations.
• Mitochondrial substrate disorders present as a model for seemingly heterogeneous genetic diseases.

Purpose of the Study:

• To investigate if shared biological processes, rather than individual gene functions, explain the localization of neurological disease phenotypes.
• To test the hypothesis that gene sets sustaining concerted biological processes lead to common or localizable phenotypes.
• To analyze mitochondrial substrate disorders as a paradigm for disease localization.

Main Methods:

• Analysis of publicly available transcriptomes and Human Ontology classifications for 27 mitochondrial substrate metabolism diseases.
• Correlation of disease phenotypes with regional brain gene expression patterns.
• Comparison with known associations between transcriptome expression and dementia atrophy resistance.

Main Results:

• Phenotypic manifestations and affected brain structures in mitochondrial substrate disorders were highly consistent across different causal genes.
• These consistent phenotypes correlated with the regional abundance of transcriptomes involved in mitochondrial substrate metabolism.
• Dysfunction in inhibitory neurons, linked to mitochondrial diseases, also showed regional transcriptome correlations.

Conclusions:

• Disease manifestations are strongly influenced by the regional expression of broad biological processes, such as mitochondrial substrate metabolism.
• Brain region or cell type dysfunction, driven by systemic processes, is more critical for disease localization than individual gene molecular function.
• This challenges the traditional view of gene function dissociation from regional brain pathology.